Clinical Trials Browser

Withdrawn × sintilimab × Gastrointestinal × Clear all

NCT04625543 2022-04-26

Neoadjuvant Immunotherapy to ESCC

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma